Table 3.

Sub-analysis of risk factor/metabolic changes in subjects who completed the trial.

Variable	n	Average Difference	(95% CI)	p value
Triglycerides < 1.7 mmol/L	12	0.07	(−0.20, 0.34)	0.5711
Triglycerides > 1.7 mmol/L	7	−0.73	(−1.25, −0.21)	0.0141
Total Cholesterol < 5.2 mmol/L	15	−0.27	(−0.52, −0.01)	0.0453
Total Cholesterol ≥ 5.2 mmol/L	5	−0.01	(−0.53, 0.50)	0.9516
LDL Cholesterol < 3.4 mmol/L	18	−0.14	(−0.41, 0.13)	0.2821
LDL Cholesterol ≥ 3.4 mmol/L	2	0.02	(−0.23, 0.27)	0.5
HDL Cholesterol ≥ 1 mmol/L	17	0.06	(−0.034, 0.16)	0.1796
HDL Cholesterol < 1 mmol/L	2	0.09	(−0.04, 0.22)	0.07
HbA1C < 42 mmol/L	8	−4.12	(−12.74, 4.50)	0.2958
HbA1C ≥ 42 mmol/L	6	−4.67	(−9.00, −0.33)	0.0395
BMI < 30	16	−1.05	(−1.73, −0.73)	0.005
BMI ≥ 30	13	−1.47	(−2.53, −0,41)	0.0105
Abdominal circ. ≥ 102 cm	21	−5.07	(−8.15, −0.98)	0.0026
Abdominal circ. < 102 cm	8	−3.28	(−6.20, −035)	0.0328
Systolic BP ≥ 130 mmHg	24	−16.04	(−23.26, −8.82)	0.0001
Systolic BP < 130 mmHg	9	−0.78	(−14.09, 12.53)	0.89
Diastolic BP ≥ 85 mmHg	11	−9.55	(−17.86, −1.23)	0.0028
Diastolic BP < 85 mmHg	18	−1.39	(−5.56, −2.79)	0.49

CI confidence interval.